Targacept, a spinoff of R.J. Reynolds Tobacco aimed at finding medicinal uses for nicotine.

PositionRegional Report: Triad - Targacept Inc. receives venture capital funding - Brief Article

WINSTON-SALEM -- Targacept, a spinoff of R.J. Reynolds Tobacco aimed at finding medicinal uses for nicotine, has landed $46 million in venture capital. Financing was led by Nomura International's Healthcare Private Equity Group, based in London. Targacept will use...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT